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Abstract
Heme oxygenase (HO)-1 is a stress response enzyme which presents with cardiovascular protective and anti-inflammatory
properties. Six-month chronic overcirculation-induced pulmonary arterial hypertension (PAH) in piglets has been previously
reported as a model of right ventricular (RV) failure related to the RV activation of apoptotic and inflammatory processes.
We hypothesized that altered HO-1 signalling could be involved in both pulmonary vascular and RV changes. Fifteen
growing piglets were assigned to a sham operation (n = 8) or to an anastomosis of the left innominate artery to the
pulmonary arterial trunk (n = 7). Six months later, hemodynamics was evaluated after closure of the shunt. After euthanasia
of the animals, pulmonary and myocardial tissue was sampled for pathobiological evaluation. Prolonged shunting was
associated with a tendency to decreased pulmonary gene and protein expressions of HO-1, while pulmonary gene
expressions of interleukin (IL)-33, IL-19, intercellular adhesion molecule (ICAM)-1 and -2 were increased. Pulmonary
expressions of constitutive HO-2 and pro-inflammatory tumor necrosis factor (TNF)-a remained unchanged. Pulmonary
vascular resistance (evaluated by pressure/flow plots) was inversely correlated to pulmonary HO-1 protein and IL-19 gene
expressions, and correlated to pulmonary ICAM-1 gene expression. Pulmonary arteriolar medial thickness and PVR were
inversely correlated to pulmonary IL-19 expression. RV expression of HO-1 was decreased, while RV gene expressions TNF-a
and ICAM-2 were increased. There was a correlation between RV ratio of end-systolic to pulmonary arterial elastances and
RV HO-1 expression. These results suggest that downregulation of HO-1 is associated to PAH and RV failure.
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Introduction
Pulmonary arterial hypertension (PAH) is a rare and fatal
disease characterized by abnormal pulmonary vasoconstriction
and pulmonary arteriolar remodeling both leading to a progressive
increase in pulmonary vascular resistance (PVR) and eventual
right ventricular (RV) failure [1]. Despite recent advances
achieved in the management of PAH, the prognosis of PAH
patients remains poor, with low quality of life and high mortality
rate in the majority of them [2]. This may be related to limited
efficacy of targeted therapies in decreasing PVR and pulmonary
arteriolar remodeling imposing an increasingly larger load on the
RV. The patient outcome is predominantly determined by the
response of the RV to the increased afterload [3–4]. Little is
known about the mechanisms responsible for the development of
RV dysfunction on PAH.
Chronic systemic-to-pulmonary shunting in growing piglets has
been shown to reproduce in a 3-month period of time typical PAH
[5–7] and in 6-month typical RV failure [6] features that may
require decades of life to develop in patients. In this experimental
end-stage PAH model, we previously reported that RV failure was
associated with myocardial activation of apoptotic and inflamma-
tory processes [8], like also observed in RV failure on transient
pulmonary artery banding in dogs [9–10], suggesting common
features in the pathobiology of acute and chronic RV failure.
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The inducible isoform of heme oxygenase, the HO-1, plays
critical roles in regulating inflammatory and cytoprotective
processes [11]. HO-1 catalyses the degradation of heme into
carbon monoxide, biliverdin and iron [12]. Its activation
potentially participates in cellular defense, oxidative stress
reduction, inhibition of the activation of inflammation and
apoptosis, all due to removal of heme and because of the
biological activity of HO-1 products.
CO is an effective pulmonary vasodilator [13], which may act
similarly to nitric oxide (NO), activating soluble guanylate cyclase
and elevating cGMP production. It inhibits platelet aggregation,
reduces leucocyte adhesion, decreases apoptosis and lowers the
production of pro-inflammatory cytokines [14–15]. Via these
properties, HO-1 could be therefore implicated in the pathogen-
esis of PAH and RV failure, controlling inflammatory phenotype.
In the present study, we took advantage of lung and myocardial
tissue stored during previous experiments in pigs with advanced
PAH-induced RV failure after 6-month chronic systemic-to-
pulmonary shunting to determine the expression of anti-inflam-
matory and cytoprotective HO-1 and to further explore the
activation of inflammatory processes in pulmonary hypertensive
disease and RV failure.
Materials and Methods
The present study was approved by the Institutional Ethics
Committee on Animal Welfare from the Faculty of Medicine at
the Universite´ Libre de Bruxelles (Brussels, Belgium) (Permit Number:
181N) and was done in accordance with the ‘‘Guide for the Care
and Use of Laboratory Animals’’ of the United States.
Protocol - Data Acquisition and Analysis
Fifteen 1861 days old piglets weighing 5.460.3 Kg were
assigned to a sham operation (n= 8) or to an anastomosis between
the left inominate artery and the pulmonary artery trunk (n= 7), as
previously reported [5–8]. After 6-month follow-up, the animals
were anaesthetized and equipped with catheters and an ultrasonic
flow probe placed around the pulmonary artery, as previously
described [5–8]. Hemodynamic evaluation was performed after
shunt closure to avoid flow-sensitive variability. Flow-resistive
properties of the pulmonary vessels were further assessed by
multipoint mean pulmonary artery pressure (mPpa)/cardiac index
(Q) plots obtained by rapid inflation of the inferior vena cava
balloon [16]. The ventricular function was estimated by pressure-
volume relationships obtained by a ‘single beat method’ used to
evaluate RV afterload by pulmonary arterial elastance (Ea) and
RV contractility by end-systolic elastance (Ees), and the adequacy
of the RV systolic function adaptation to the afterload by the Ees/
Ea ratio [17]. At the end of the protocol, the animals were
euthanatized with a barbituric overdose. Lung and RV tissue were
sampled, immediately snap-frozen in liquid nitrogen and stored at
-80uC for biological analysis or after overnight fixation, embedded
in paraffin for morphometric evaluations. Lung tissue and RV free
wall were collected and stored from 7 sham and 7 shunted pigs
during previous experiments [8] and from one sham pig during
new experiments.
Morphometry
Pulmonary arterial morphometry was performed as previously
described [5–8]. Only the smallest pulmonary resistive arterioles
with an external diameter (ED) of ,75 mm and a complete
muscular coat were measured. Medial thickness (MT) was related
to arterial size with the following formula: %MT= (2xMT/ED)6
100 and performed by counting at least 50 pulmonary arteries per
lung section from each pig.
Real-time Quantitative Polymerase Chain Reaction (RTQ-
PCR)
Total RNA was extracted from snap-frozen pulmonary and
myocardial tissue using the QIAGEN RNeasyTM Mini kit
(QIAGEN, Hilden, Germany), according to the manufacturer’s
instructions. Concentration of total RNA was determined by
standard spectrophotometric techniques and RNA integrity was
assessed by visual inspection of GelRed (Biotium, Hayward, CA)-
stained agarose gels. Reverse transcription was performed using
random hexamer primers and SuperscriptTM II Reverse Tran-
scriptase (Invitrogen, Carlsbad, CA, USA), according to the
manufacturer’s instructions.
For RTQ-PCR, sense and antisense primers were designed
using Primer3 program for porcine heme oxygenase (HO)-1, HO-
2, tumor necrosis factor (TNF)-a, intercellular adhesion molecule
(ICAM)-1, ICAM-2, vascular cell adhesion protein (VCAM)-1,
interleukin (IL)-33, interleukin 1 receptor-like 1 (ST2), IL-19 and
signal transducer and activator of transcription (STAT)-3 mRNA
sequences (Table 1). To avoid inappropriate amplification of
residual genomic DNA, intron-spanning primers were selected
when exon sequences were known. For each sample, amplification
reaction was performed in triplicate using SYBR-Green PCR
Master Mix (Quanta Biosciences, Gaithersburg, MD, USA),
specific primers and diluted template cDNA. Result analysis was
performed using iCycler System (Biorad Laboratories). Relative
quantification was achieved with the comparative 22DDCt method
by the normalization with the housekeeping gene (hypoxanthine
phosphoribosyltransferase-1, HPRT1) [18].
Western Blotting
Proteins were extracted from snap-frozen pulmonary and
myocardial tissue by homogenization in an appropriate ice-cold
lysis buffer, as previously described [19]. After centrifugation,
protein concentration was determined using the Bradford
protein assay. Protein extracts (50 mg) were resolved on 4–
12% NuPage Bis-Tris gels (Invitrogen, Carlsbad, CA, USA) and
electro-transferred to nitrocellulose membranes (BioRad, Her-
cule, CA, USA). After blocking with 5% non-fat milk in 0.1%
Tween-TBS (Tris–HCl (pH 8.0); NaCl 150 mM), membranes
were incubated with rabbit anti-HO-1 (1:500; Sigma-Aldrich, St
Louis, MO, USA) monoclonal antibody. After incubation with
secondary HRP-conjugated anti-mouse antibody (1:25000;
ThermoScientific, Rockford, IL, USA), immunoreactive bands
were detected using SuperSignalTM WestPicoChemiluminescent
substrate (ThermoScientific, Rockford, IL, USA) and quantified
by laser densitometry (Bio 1D software; Viber Lourmat, Marne
La VAlle´e, France). Relative quantification was systematically
performed by normalization with b-actin (Sigma-Aldrich, St
Louis, MO, USA) on each blots. Samples from sham and
shunted pigs were randomly tested in each Western Blot and
one randomly chosen reference sample was deposited on all
different blots to allow the comparison and the quantification of
all different blots together.
Statistical Analysis
Values are reported as mean 6 standard error of the mean
(SEM). Statistical analyses were performed using StatView 5.0
Software. The hemodynamic and biological data of 6-month shunt
and 6-month sham groups were compared by performing one-way
analysis of variance (one-way ANOVA). When the F ratio of this
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analysis resulted in a P-value of 0.05 critical value, comparisons
were made with a modified two-tailed Student’s t-test [20]. P-
values 0.05 were considered statistically significant. Five-point
mPpa/Q plots were obtained in all animals, and always best
described by a linear approximation, with correlation coefficients
higher than 0.95. A linear regression was calculated on each of
them by the least squares method Plots of mPAP as a function of Q
were compared by t-tests on slopes or on interpolated mPAP at
cardiac indexes of 2 and 5 L.min21.m22.
Results
Hemodynamic and Morphometric Evaluation
Six-month chronic systemic-to-pulmonary shunting increased
mean pulmonary artery pressure (mPpa) (sham (1761 mmHg) vs
shunt (2262 mmHg), p= 0.04), pulmonary vascular resistance
(PVR) (sham (2.660.2 mmHg.L21.min.m22) vs shunt
(6.461 mmHg.L21.min.m22), p = 0.01) and occluded Ppa (Ppao)
(sham (761 mmHg) vs shunt (1161 mmHg), p = 0.0004) with no
change in mean systemic artery pressure (mPsa). As already
partially reported elsewhere [8], the mPpa/Q relationships were
shifted to higher pressures with an increase in slope hellosham
(3.460.4 mmHg.L21.min.m22) vs shunt
(7.260.6 mmHg.L21.min.m22), p = 0.0003] (8). There was a
marked decrease in Ees/Ea ratio (sham (1.5160.06) vs shunt
(0.6860.07), p = 0.000001) [8], indicating a RV-arterial uncou-
pling in the 6-month shunted compared with the 6-month sham-
operated pigs. Cardiac index (Q) (sham (3.560.3 L.min21.m22) vs
shunt (1.960.1 L.min21.m22), p = 0.0002) [8] and stroke volume
decreased (sham (4265 mL.Beat21) vs shunt (2765 mL.Beat21),
p = 0.003) and right atrial pressure (Pra) tended to increase (sham
(6.160.3 mmHg) vs shunt (7.160.5 mmHg), p = 0.09).
Six-month aorta-pulmonary shunting was associated with
increased Z0 and ZC impedance (Figure 1).
After 6-month systemic-to-pulmonary shunting, pulmonary
arterial thickness increased, mostly in the smallest pulmonary
arteries (,75 mm) (Figure 2).
Pulmonary Hypertensive Disease - Pulmonary
Expressions of Heme Oxygenases and Cell Adhesion
Molecules
Systemic-to-pulmonary shunting was associated with a non
significant but strong tendency to the decreased gene (p= 0.06)
and protein (p = 0.07) expressions of inducible HO-1 isoenzyme in
lung tissue (Figure 3A and 3B), while pulmonary gene expression
of constitutive HO-2 isoenzyme did not change (Figure 3A). As
illustrated in Figure 3A, pulmonary gene expressions of cell surface
glycoproteins mediating inflammatory cell adhesion, such as
ICAM-1 and ICAM-2 increased, while pulmonary expression of
VCAM-1 did not change.
Pulmonary Hypertensive Disease - Pulmonary
Expressions of Tumor Necrosis Factor(TNF)- a,
Interleukins (IL )-33 and -19
As illustrated in Figure 3A, pulmonary gene expression of pro-
inflammatory TNF-a did not change after 6-month systemic-to-
pulmonary shunting.
In the 6-month shunted group, pulmonary gene expression of
IL-33, a pro-inflammatory cytokine belonging to the IL-1 cytokine
family, increased, while pulmonary expression of ST2, a decoy
receptor which negatively regulates IL-1/IL-33 signaling pathway,
did not change (Figure 3A).
Six-month systemic-to-pulmonary shunting increased pulmo-
nary gene expression of anti-inflammatory IL-19, a cytokine
belonging to the IL-10 cytokine family, while pulmonary
expression of STAT3, the transcription factor downstream
activated, remained unchanged (Figure 3A).
Right Ventricular Failure – RV Expressions of Heme
Oxygenases and Inflammatory Mediators
As illustrated in figure 4, systemic-to-pulmonary shunting
decreased the RV relative gene expression of inducible HO-1
isoenzyme (Figure 4A), while RV protein expression tended to
decrease, but not significantly (p = 0.07) (Figure 4B). RV gene
expression of constitutive HO-2 expression remained unchanged
(Figure 4A).
RV failure was associated with increased RV gene expressions
of TNF-a and ICAM-2, while RV expressions of ICAM-1,
VCAM-1, IL-33, ST2, IL-19 and STAT3 remained unchanged
(Figures 4A).
Table 1. Primers used for RTQ-PCR in porcine lung and
myocardial tissue.
Genes Primer Sequences
HO-1
Sense 59-ATGTGAATGCAACCCTGTGA-39
Antisense 39-GGAAGCCAGTCAAGAGACCA-59
HO-2
Sense 59-CGCAGCAGTTCAAGCAGTT-39
Antisense 39-CCTCCTCCACGATCTTCTCTT-59
TNF-a
Sense 59-TCTGGACTTTGCTGAATCTGG-39
Antisense 39-TGAGGGGGTCTGAAGGAGTAA-59
ICAM-1
Sense 59-GCTATCTTGGGCAGTGTTGG-39
Antisense 39-AGGCTGGTGTGCTAAGTTTCA-59
ICAM-2
Sense 59-GCCCACTTTTGTGACCGTAG-39
Antisense 39-GGTGATGGTGAGGGTTTCA-59
VCAM-1
Sense 59-GAGTTAATCCGGTTGGGACA-39
Antisense 39-TTCACAGAACTGCCCTCCTC-59
IL-33
Sense 59-CCGGCAAAGTCTCGATAAAA-39
Antisense 39-ATGATAAGGCCAGAGCGAAG-59
ST2
Sense 59-CCTGGAGTTCATTCCCTCTG-39
Antisense 39-GGAGATTGTTGGTGCTCCTT-59
IL-19
Sense 59-CGAGGTCTCAGGAGGTGTCT-39
Antisense 39-GATGGTGACATTTTGCATGG-59
STAT3
Sense 59-CGCAGAGTTCAAACACCTGA-39
Antisense 39-AGCTCCTCGGTCACAATGAG-59
doi:10.1371/journal.pone.0069470.t001
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Correlations
To assess whether there might have been a link between the
inflammatory phenotype and the development of PAH, we looked
for correlations between typical PAH features, such as the PVR
(obtained as the slope of multipoint mPpa/Q plots) or the
pulmonary arteriolar remodeling and the pulmonary expressions
of HO-1 and biological determinants implicated in inflammatory
processes. PVR was inversely correlated to pulmonary expressions
of ICAM-1 (Figure 3C), ICAM-2 and pro-inflammatory IL-33
(Figure 3C) and inversely correlated to pulmonary expressions of
cytoprotective and anti-inflammatory HO-1 (Figure 3C) and anti-
inflammatory IL-19 (Figure 3C). There was a negative correlation
between the percentage of medial thickness of pulmonary
arterioles ,75 mm and the pulmonary gene expression of IL-19
(Figure 2).
To understand better the link between inflammatory phenotype
and RV adaptation to the increased afterload, we also looked for
correlations between Ees/Ea ratio and different inflammatory
determinants. There was a positive correlation between RV Ees/
Ea ratio and RV protein expression of cytoprotective and anti-
inflammatory HO-1 (Figure 4C) and a negative correlation
between with RV ICAM-2 gene expression (Figure 4C).
Discussion
The present results suggest that decreased HO-1 expression and
local activation of inflammatory processes are associated to both
pulmonary vascular and RV remodeling in pulmonary hyperten-
sion on six-month chronic systemic-to-pulmonary shunting in
growing piglets.
We previously reported on RV failure induced by 6 months of
aorta-pulmonary shunting in growing piglets [8]. The present
study further explored pulmonary hemodynamics and associated
biological changes in these animals. Pulmonary artery impedance
measured at 0Hz (Z0) and characteristic impedance (Zc) were
increased, which is in keeping with previous report on 3-month
piglets [21]. Right ventricular afterload and hydrolic load is best
described by a pulmonary arterial impedance (PVZ) spectrum,
which integrates pulmonary vascular resistance (PVR), elastance,
and wave reflection [16,21]. Increases in Z0, or total PVR,
calculated as Ppa/Q, may be related with the changes in medial
thickness in distal and resistive arterioles whereas increases in
characteristic impedance (Zc), ratio between the inertance and
compliance of the proximal pulmonary arterial tree [21], could be
interpreted as a decrease of pulmonary artery compliance related
with structural and/or functional modifications in proximal
pulmonary artery. PVR was defined by multipoint mPAP-flow
plots. This approach is superior to single point PVR calculations as
the slope of mPAP-flow may be less than predicted by the PVR
equation because of recruitment, distension or both [22].
Inflammation has been shown to play roles in human and
experimental pulmonary hypertension (PH) and is increasingly
recognized as a major pathogenic component of the pulmonary
vascular remodeling in pulmonary arterial hypertension (PAH)
[23]. Moreover, disturbances in homeostatic processes regulating
neurohumoral activation, oxidative stress, inflammation and
apoptosis have also been suggested to participate to RV failure
in PH [24]. We have recently reported that RV failure on
prolonged systemic-to-pulmonary shunting in growing piglets [8]
and on transient pulmonary artery banding in dogs [9,10] are
associated with increased activation of apoptosis and inflamma-
tion, including overexpressions of pro-inflammatory cytokines.
This reinforces the notion that inflammation seems to play crucial
roles in the pathogenesis of PAH and RV failure.
In the present study, pulmonary expressions of ICAM-1 and
ICAM-2 were increased after 6-month systemic-to-pulmonary
shunting, while VCAM-1 expression did not change. The ICAM
glycoproteins which are normally weakly expressed by endothelial
cells, have been shown to be upregulated after injury and
responsible for the orchestration of the recruitment and the
attachment of inflammatory cells to the endothelium. This
represents a marker of endothelial activation [25], acting as a
prelude to the migration of inflammatory cells into other vascular
layers and probably contributing to the vascular remodeling.
Pulmonary overexpression of ICAM-1 has been observed in rats
with monocrotaline injection [26]- and chronic hypoxia exposure
[27–28]-induced PH. Moreover, increased flow pulsatility has
been shown to induce endothelial expression of inflammatory
Figure 1. Pulmonary hemodynamics. Zo and Zc. Black squares or columns: shunt, empty circles and empty columns: sham piglets. Values
expressed as mean6SEM. P values indicate significances on comparisons of means of Z0 and Zc.
doi:10.1371/journal.pone.0069470.g001
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genes, including ICAM-1 [29], suggesting that prolonged shunt-
induced overcirculation could contribute to the development of an
inflammatory phenotype in the lungs of the present experimental
model. In accordance with the present results showing a tight
relation between pulmonary ICAM-1 expression and the PVR,
the severity of the pulmonary hypertensive disease has been tightly
correlated to serum level of soluble ICAM-1 in patients with
congenital heart disease and PH [2].
In the present experimental model of PAH, IL-33 was
overexpressed in the lungs, while expression of its ST2 receptor
remained unchanged. Recently described member of the IL-1
cytokine family, IL-33 is a strong inducer of T helper 2 (Th2)
immune responses [30] and contributes to the early events in
endothelial activation, promoting endothelial expression of adhe-
sion molecules (e.a. ICAM-1 and VCAM-1) and pro-inflammatory
chemokines (e.a. monocyte chemoattractant protein-1) [31]. IL-33
could therefore contribute to the endothelial activation and
subsequent pulmonary arterial remodeling in PAH. Normally
released by necrotic cells as an ‘‘alarming factor’’ alerting the
immune system to tissue damage or stress, mechanical strain has
also been shown to induce the secretion of IL-33 in fibroblasts in
the absence of cellular necrosis [32]. Via its binding to the ST2
receptor, IL-33 also strongly induces Th2 cytokine production (e.a.
IL-4, -13 and -19) from these cells and can promote the
pathogenesis of Th2-related disease, such as pulmonary arterial
remodeling [33].
Six-month systemic-to-pulmonary shunting increased pulmo-
nary expression of IL-19, while STAT3 expression did not change.
This could be seen as a Th2-related cytokine production. In
vascular smooth muscle cells, IL-19 rapidly evokes the activation
and the translocation of STAT3 transcription factor [34] which
has been recently incriminated in the development of idiopathic
PAH [35] and experimental monocrotaline injection-induced PH
[36]. IL-19 also induces the expression of the potent inflammatory
modulator HO-1 and decreases the production of reactive oxygen
species in human vascular smooth muscle cells [17]. IL-19 has
been shown to decrease dose-dependently the proliferation of
vascular smooth muscle cells [15,34,37–38], whereas, in endothe-
lial cell, HO-1 induction increases cell cycle progression [39].
Increased pulmonary IL-19 expression could be therefore partly
Figure 2. Morphometry on smallest pulmonary arterioles (,75 micrometers) obtained in Sham and Shunt piglets and labeled by
the method of von Gieson-orcein. At least 50 resistive arterioles have been measured per animal. The medial thickness (MT) has been reported in
vessel diameter following the formula %MT= [(26MT)/ED]6100 where ED is the external diameter of arterioles measured. MT in pulmonary arteries
under 75 micrometers correlated to lung tissue relative IL-19 mRNA content. Values expressed as mean6SEM.
doi:10.1371/journal.pone.0069470.g002
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responsible for the non-aggravation of the pulmonary vascular
remodeling in the 6-month compared to the 3-month shunted pigs
[5,8].
In the present study, we found a trend to the decreased
expression of HO-1 in the lungs after 6-month systemic-to-
pulmonary shunting. Overexpression of HO-1 has been shown to
Figure 3. Panel A: Relative lung tissue mRNA content for the heme-oxygenase(HO)-1 and -2 tumor necrosis factor(TNF)-a,
intercellular adhesion molecule(ICAM)-1 and -2, vascular cell adhesion molecule(VCAM)-1, interleukin(IL)-33, interleukin 1
receptor-like 1 (ST2), interleukin(IL)-19 and signal transducer and activator of transcription(STAT)-3 in 6-month sham (white bars)
and 6-month shunt (black bars) piglets. Panel B: Relative lung tissue protein content for the heme-oxygenase(HO)-1 in 6-month sham (white
bars) and 6-month shunt (black bars) piglets. Panel C: Correlation between slope of mPpa/Q relationships and lung protein content for heme-
oxygenase(HO)-1, lung mRNA content for intercellular adhesion molecule(ICAM)-1, interleukin(IL)-33 and interleukin(IL)-19. Values expressed as
mean6SEM.
doi:10.1371/journal.pone.0069470.g003
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prevent the development of hypoxia-induced PH, associated with
reduced pulmonary inflammation (characterized by increased
macrophage activity and IL-10 expression [40])and vascular
remodeling [41–42]. HO-1 mediates in vivo the protective effects
in monocrotaline-induced PH and in vitro the anti-proliferative
effects in smooth muscle cells of rapamycin [43]. In contrast,
Figure 4. Panel A: Relative right ventricular (RV) tissue mRNA content for the heme-oxygenase(HO)-1 and -2, tumor necrosis
factor(TNF)-a, intercellular adhesion molecule(ICAM)-1 and -2, vascular cell adhesion molecule(VCAM)-1, interleukin(IL)-33,
interleukin 1 receptor-like 1 (ST2), interleukin(IL)-19 and signal transducer and activator of transcription(STAT)-3 in 6-month sham
(white bars) and 6-month shunt (black bars) piglets. Relative right ventricular (RV) tissue protein content for the heme-oxygenase(HO)-1 in 6-
month sham (white bars) and 6-month shunt (black bars) piglets. Correlation between Ees/Ea ratio and right ventricular (RV) protein content for
heme-oxygenase (HO)-1 and right ventricular (RV) mRNA content for intercellular adhesion molecule (ICAM)-2. Values expressed as mean6SEM.
doi:10.1371/journal.pone.0069470.g004
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pulmonary HO-1 expression has been shown to be increased in
monocrotaline- and monocrotaline/pneumectomy-induced PH
[44].
Here, we also showed decreased gene expression of HO-1 in the
failing RV. These results suggest a similar tendency to changes in
HO-1 in the lungs and the failing RV in the present experimental
model of advanced PAH, probably through divergent HO-1
enzymatic products [45]. Indeed, biliverdin has been shown to
prevent RV dysfunction, but did not reduce the pulmonary artery
remodeling, while inhaled CO reduced the pulmonary vascular
remodeling, but did not have any effect on the RV (45). In mice
exposed to chronic hypoxia, administration of mesenchymal cells
overexpressing HO-1 has been shown to reduce the RV
hypertrophy, to stabilize the infarction zones and to decrease the
RV systolic pressure to normal values [46]. The RV HO-1
expression has been shown to be increased and decreased
respectively in experimental models of RV pressure overload
[47] and RV failure [48]. In patients with end-stage congenital
heart disease, RV levels of HO-1 were increased with variable
magnitude [49]. This suggests that HO-1 expression seems to
depend on the stress-induced cardiomyocyte damage and the
evolution of RV failure.
In the present study, the decreased HO-1 expression was related
to the activated inflammatory phenotype in the RV, as assessed by
increased RV ICAM-2 expression and previously shown increased
RV IL-1a, IL-1b and TNF-a expressions [8]. Moreover, the RV
IL-33 expression did not change. IL-33 is mainly produced by
cardiac fibroblasts in response to mechanical strain. In the left
ventricle, IL-33 has been shown to prevent cardiomyocyte
hypertrophy though its soluble ST2 receptor [50]. After chronic
exposure to pressure overload induced by transverse aortic
constriction, transgenic ST2-deficient mice developed more
ventricular hypertrophy, cavity dilations and fibrosis and had
only a limited survival rate. Moreover, IL-33 administration
reduced ventricular hypertrophy and fibrosis and improved the
survival rate in the control mice but not in ST2-deficient mice
[50]. Mechanically activated IL-33/ST2 signalling could be,
therefore, responsible for a cardioprotective paracrine system
regulated by cardiac fibroblasts. In the present experimental
model of RV failure, myocardial gene expressions of IL-33 and
ST2 remained unchanged in the 6-month shunted and sham pigs.
This observation suggests that the cardioprotective mechanism
depending on the activation of the IL-33/ST2 signalling pathway
fails to be activated in the failing RV and probably implicated in
the pathogenesis of RV failure.
In conclusion, the present study shows that PAH and RV failure
are associated with downregulation of HO-1 signaling and local
activation of inflammatory processes.
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